Oh, Young S., and R. James Turner. Evidence that the COOH terminus of human presenilin 1 is located in extracytoplasmic space. PS1) is a component of the ␥-secretase complex that is responsible for the intramembranous cleavage of several type I transmembrane proteins, including the ␤-amyloid precursor protein (APP). Mutations of PS1, apparently leading to aberrant processing of APP, have been genetically linked to early-onset familial Alzheimer's disease. PS1 contains 10 hydrophobic regions (HRs) sufficiently long to be ␣-helical membrane spanning segments. Most topology models for PS1 place its COOH terminal ϳ40 amino acids, which include HR 10, in the cytosolic space. However, several recent observations suggest that HR 10 may be integrated into the membrane and involved in the interaction between PS1 and APP. We have applied three independent methodologies to investigate the location of HR 10 and the extreme COOH terminus of PS1. The results from these methods indicate that HR 10 spans the membrane and that the COOH terminal amino acids of PS1 lie in the extracytoplasmic space.
PRESENILIN 1 (PS1) is thought to be the proteolytic component of the ␥-secretase complex that is responsible for the intramembranous cleavage of several type I transmembrane proteins, including the ␤-amyloid precursor protein (APP) (1, 24, 27) . Mutations in PS1 have been genetically linked to cases of early-onset familial Alzheimer's disease (25) . These mutations apparently lead to aberrant processing of APP, resulting in increased production of the longer neurotoxic form of ␤-amyloid found in the characteristic senile plaques observed in the brains of Alzheimer's patients (1, 24, 27) . Because of its role in the processing of APP, ␥-secretase, and thereby PS1, is considered to be a major therapeutic target for the treatment of Alzheimer's disease.
PS1 is a ϳ50-kDa integral membrane protein. In cells the PS1 holoprotein is rapidly endoproteolyzed by cleavage near Met292. The resulting ϳ30 kDa NH 2 terminal fragment (NTF) and ϳ20 kDa COOH terminal fragment (CTF) are found in high molecular weight complexes with the integral membrane proteins nicastrin, PEN-2, and APH-1, which together are thought to constitute the ␥-secretase (27) . Recent evidence suggests that the components of these complexes not only stabilize PS1 but are also involved in its maturation by endoproteolysis (20, 26 ).
An understanding of the transmembrane topology of PS1 is clearly essential to the interpretation of its role in ␥-secretase activity. Hydropathy analysis shows that PS1 contains 10 hydrophobic regions (HRs) sufficiently long to form ␣-helical membrane spanning segments (MSSs; Fig. 1A ). Essentially two types of studies have been performed by various groups to study the PS1 topology: 1) experiments examining antibody epitope accessibility before and after plasma membrane permeabilization (5) (6) (7) (8) , and 2) experiments examining the membrane integration of truncated forms of PS1 (17, 21) or SEL-12 (18, 19) , a PS1 homologue from Caenorhabditis elegans. In these latter experiments, reporter peptides were fused to PS1 or SEL-12 truncated after each HR and these chimeric proteins were expressed in isolated microsomes or intact cells. Assays were then carried out to determine the location of the reporter peptide in the cytosolic or extracellular compartment, allowing one to infer the ability of each successive HR to integrate into the membrane.
All of the above studies (recently reviewed in Ref. 14) agree that HRs 1-6 are MSSs and that HR 7 is left out of the membrane so that the NH 2 terminus of PS1 and the "loop" region between HRs 6 and 8 are on the same side of the membrane. Most groups propose that the NH 2 terminus and loop are cytosolic; however, Dewji and Singer (6, 7) have presented evidence from antibody accessibility studies that they are exposed on the extracellular surface of intact cells. There is some disagreement as to whether HRs 8 and 9 span the membrane or are peripherally associated with it, but all groups find that the COOH terminal end of HR 9 faces the cytoplasm and all groups but one (21) find that HR 10 is left out of the membrane on the cytosolic side. In these latter dissenting studies, Nakai et al. (21) found that a glycosylation tag appended to the end of full-length PS1 was glycosylated when this fusion protein was expressed in the presence of dog pancreatic microsomes or in COS-1 cells. Nakai et al. concluded that HR 10 was a MSS so that the COOH terminus of PS1 was located in the lumen of the endoplasmic reticulum (ER). But this observation has been largely ignored and a topology model suggested by Li and Greenwald, based mainly on studies carried out on SEL-12 (18, 19) , is most commonly accepted (14) . This model proposes that the NH 2 terminus of PS1 is cytosolic, HRs 1-6, 8, and 9 are MSSs, and HR 10 is left out of the membrane on the cytosolic side.
Recently, however, Annaert et al. (2) have found evidence that the COOH terminal 39 amino acids of PS1 bind specifically to the MSSs of both APP and telencephalin, another ␥-secretase substrate. This 39 amino acid stretch begins at the COOH terminal end of HR 9 and thus includes HR 10 (Fig.  1B) . On the basis of their results, Annaert et al. (2) have proposed that the binding site in PS1 for type I membrane protein substrates actually lies within the membrane and that these 39 amino acids form a part of this binding pocket. This hypothesis is clearly difficult to reconcile with the commonly accepted view that the sequence downstream of HR 9 lies in the cytosol. In the experiments presented here, we reexamine the location of the COOH terminus of PS1 and the association of HR 10 with the membrane. We present the results of experiments carried out using three independent methodologies, which provide strong evidence that HR 10 spans the membrane and that the COOH terminus of PS1 lies in the extracytosolic compartment.
MATERIALS AND METHODS
Clones and antibodies. The human PS1 clone and Swedish APP mutant (APP 695⌬NL) were generously provided by Dr. Todd E. Golde (Mayo Clinic Jacksonville). We utilized commercial rabbit polyclonal antibodies against calregulin, the NH 2 terminal 70 amino acids of human PS1 (PS1-N), the NH2 terminus of calnexin (all from Santa Cruz Biotechnology), and green fluorescent protein (GFP; Molecular Probes). Mouse monoclonal antibody (PS1-loop) that had been raised against amino acids 263-378 of human PS1 was purchased from Chemicon. The rabbit polyclonal antibodies 4627, raised against the COOH terminal 10 amino acids of PS1 (22) , and PS1-C (29) raised against the COOH terminal 14 amino acids of PS1, were generous gifts from Dr. Dennis Selkoe (Harvard Medical School) and Dr. Hui Zheng (Baylor College of Medicine), respectively.
Cell culture and transfection. Human embryonic kidney (HEK)-293 and HEK-293T cells were cultured and transfected as previously described (9) . The PS1/PS2 double-knockout cell line BD1 (11), a generous gift from Dr. Alan Bernstein (Mt. Sinai Hospital, Toronto, Ontario, Canada), was cultured as described (30) and transfected with the use of FuGENE (Roche).
Preparation of ER vesicles and proteinase K digestion. The procedure for the proteinase K experiments was based on that of Feramisco et al. (12) with some modifications. Briefly, HEK-293 cells were collected in buffer A, composed of (in mM) 10 HEPES-KOH, pH 7.4, 10 KCl, 1.5 MgCl 2, 5 Na-EDTA, 5 Na-EGTA, and 250 sucrose (all steps at 4°C), homogenized by being passed through a 22-gauge needle 15 times, and centrifuged at 3,000 g for 10 min. The supernatant was centrifuged at 20,000 g for 15 min, and the resulting pellet, containing sealed cytosolic side out ER vesicles (see RESULTS) , was resuspended in buffer A containing 100 mM NaCl. Aliquots of this preparation (2-4 g of protein) were treated with 2 mg/ml proteinase K (Sigma, P5568) in the presence or absence of 1% Triton X-100 in a total volume of 12 l for 30 min on ice. The reaction was stopped by the addition of PMSF at a final concentration of 20 -30 mM. Samples were then subjected to SDS-PAGE and immunoblot analysis.
DNA constructs. The segments of the human PS1 sequence indicated were cloned into the mammalian expression vector pEGFP-␤ (10). This vector drives the expression of a fusion protein consisting of the enhanced GFP (EGFP), followed by BglII and HindIII restriction sites for the insertion of (PS1) sequence and a COOH terminal glycosylation tag.
Site-directed mutagenesis was carried out using the Quikchange and Quikchange II XL kits (Stratagene) used according to the manufacturer's instructions.
Preparation and deglycosylation of membrane fractions. Particulate fractions were prepared from HEK-293T cells transiently transfected with pEGFP-␤ constructs, as previously described (10) . A membrane fraction was prepared from this particulate fraction by alkaline floatation essentially as previously described (10) , except that all sucrose solutions were buffered with 100 mM Na 2CO3 (pH 11.5). The membrane fractions were deglycosylated with the use of peptide: N-glycosidase F (PNGase F; New England Biolabs) (10) .
SDS-PAGE, Western blot, and data analysis. SDS-PAGE and Western blot analysis were carried out as previously described (10) . Quantitation of Western blots was done with the use of ImageQuant 5.2 software (Molecular Dynamics).
RESULTS AND DISCUSSION
Proteinase K digestion. Endogenously expressed PS1 is found predominantly in the ER and in early ER to cis-Golgi compartments (3, 15, 28) . To examine the location of the NH 2 and COOH termini and the loop region of endogenously expressed PS1 relative to the ER membrane we isolated ER vesicles from HEK-293 cells and subjected them to proteinase K digestion in the presence or absence of 1% Triton X-100 (see MATERIALS AND METHODS). When we assayed this preparation via Western blot analysis for calregulin, an ER luminal protein, and calnexin, an ER membrane protein, we found that 99.0 Ϯ 5.6% (n ϭ 10) and 95.6 Ϯ 3.2% (n ϭ 8), respectively, of their immunoreactive signals were preserved after proteinase K treatment ( Fig. 2A) . In addition, the apparent molecular mass of calnexin was shifted downward ϳ10 kDa by proteinase K consistent with the digestion of its cytosolic ϳ90 amino acid COOH terminus. Both the calregulin and calnexin signals were lost when digestion was carried out in the presence of 1% Triton X-100, which solubilizes the vesicle membrane. Taken together, these results demonstrate that virtually all of the ER membranes in this preparation are in the form of sealed cytosolic side out vesicles. When these vesicles were probed with the antibodies PS1-N, raised against the NH 2 terminus of PS1, and PS1-loop, raised against the loop region, we found that only 4.4 Ϯ 2.0% (n ϭ 7) and 5.0 Ϯ 1.4% (n ϭ 7), respectively, of their immunoreactive signals remained undigested after proteinase K treatment (Fig. 2B ). This undigested material was at the molecular weight of the full length NTF and CTF, recognized by PS1-N and PS1-loop, respectively. Thus at least 95% of the PS1 molecules in this preparation are oriented with their NH 2 termini and loop regions facing the cytoplasmic side of the ER where they are accessible to proteinase K. In additional experiments, where we varied proteinase K concentration and/or digestion time, we were unable to decrease the remaining signals from these antibodies below ϳ5% (not shown). This result may indicate that a small population of PS1 molecules are oriented with their NH 2 termini and loop regions toward the intravesicular space. However, if this were the case, one might have expected a downward shift in the molecular weight of the remaining signal due to proteinase K digestion at other accessible sites (cf., calnexin in Fig. 2A ). Accordingly we think it is more likely that these remaining signals represent PS1 molecules that for some reason are resistant to proteinase K (e.g., they may represent aggregated material).
In contrast to our results for PS1-N and PS1-loop, we find that 100.2 Ϯ 7.6% (n ϭ 9) of the immunoreactive signal of the antibody PS1-C, raised against the extreme COOH terminus of PS1, remains after proteinase K treatment. This signal is present in two bands, one at or near the molecular weight of the undigested CTF and the other at 10.0 Ϯ 0.3 kDa, representing 26.0 Ϯ 4.3% and 74.2 Ϯ 8.3% of the starting signal, respectively (Fig. 2B) . We have not attempted to determine the reason why only 5% of the full-length CTF signal is resistant to proteinase K when assayed by the PS1-loop antibody vs. 26% when assayed by the PS1-C antibody. However, it is possible that the epitope recognized by PS1-loop (a monoclonal antibody) lies near the NH 2 terminal end of the CTF and may be digested from some of the molecules detected by PS1-C near the molecular weight of the full-length CTF. In this regard, in our preliminary experiments (not shown) we noted that PS1 was considerably more resistant to digestion by proteinase K than calnexin, possibly because, as a part of a large membranebound protein complex, PS1 is relatively less accessible from the surrounding medium. Nevertheless, what is strikingly clear from Fig. 2B is that the accessibility of the extreme COOH terminus of PS1 to proteinase K is quite different from that of the NH 2 terminus and the loop region, strongly suggesting that it does not lie in the cytosolic compartment.
Reporter gene fusion. To further examine the location of the COOH terminus of PS1, we have used a gene fusion approach, where portions of the PS1 sequence were fused between EGFP and a COOH terminal glycosylation tag (see MATERIALS AND METHODS). This latter sequence contains five consensus sites for N-linked glycosylation (10); when translocated into the interior of the ER it acquires ϳ14 kDa of apparent molecular weight due to glycosylation, an increase that is easily discerned on SDS-PAGE. The utility of this experimental system for membrane topology and biogenesis studies has been previously documented (9, 10) .
In Fig. 3 we illustrate the results of experiments where PS1 fragments encoding HRs 7-9 (cHR 7-9), HRs 7-10 (cHR 7-10), HRs 1-9 (cHR 1-9), and HRs 1-10 (full-length PS1; cHR 1-10) were expressed as EGFP fusion proteins in HEK-293T cells. In Fig. 3A , we show the results of a typical experiment where the membrane fraction from HEK-293T cells, transiently transfected with the construct indicated, was treated with (ϩ) or without (Ϫ) PNGase F (see MATERIALS AND METHODS). These membrane fractions were run on SDS-PAGE and probed by Western blot analysis using an antibody against EGFP to determine their extent of glycosylation and thus the location of the glycosylation tag inside or outside the ER lumen (Fig. 3B) . Little glycosylation is seen for either cHR 7-9 or cHR 1-9, where the PS1 sequence ends after HR 9, consistent with the general consensus that the COOH terminal end of HR 9 faces the cytoplasm. However, both fusion proteins that incorporate HR 10 (cHR 7-10 and cHR 1-10) are highly glycosylated, indicating that HR 10 spans the membrane in these constructs. To confirm this interpretation, in the fusion protein cHR 1-10 (RD), we have mutated amino acids Leu443 and Val444 near the middle of HR 10 (Fig. 1B) in cHR 1-10 to Arg and Glu, respectively, dramatically reducing the hydrophobicity of HR 10. As illustrated in Fig. 3B , the glycosylation of this mutated construct is markedly reduced relative to cHR 1-10, confirming that the glycosylation of cHR 1-10 is dependent on the hydrophobicity of HR 10, consistent with its role as a MSS.
Insertion of N-linked glycosylation site. In Fig. 4 , we illustrate the results of experiments where we have transfected cells with unmodified full-length PS1 and with the clone PS1-NGT, into which we have inserted a glycosylation consensus site (AsnGlyThr) after His463, four amino acids from its COOH Fig. 4 . Effect of insertion of a glycosylation site near the COOH terminal end of PS1. A: HEK-293T cells were transfected overnight with wild-type PS1 or PS1, into which a glycosylation consensus site had been inserted after H463 (PS1-NGT). Western blot analysis was carried out using PS1-N. B: Western blots of membranes from untreated HEK-293 cells, or HEK-293 cells transiently (4 days) or stably transfected with PS1-NGT, probed with the PS1-loop antibody. The asterisk shows a band appearing only in PS1-NGT-transfected cells that is lost after treatment with PNGase F. The faint band running just above the COOH terminal fragment (CTF) in untreated as well as transfected HEK-293 cells is thought to be due to PS1 phosphorylation (16) . C: ␥-secretase activity (total APP cleavage products in the extracellular medium) was measured in mock transfected BD-1 (PS1/PS2 double knockout) cells (CTL), and in BD-1 cells transfected with the Swedish APP mutant alone [␤-amyloid precursor protein (APP)] or in combination with wild-type PS1 (APP and PS1) or PS1-NGT (APP and PS1-NGT) as indicated. Cells were transfected for 6 h on day 0, and then rested overnight. On day 1, the culture medium was changed, and aliquots were collected on day 2 (24 h) and day 3 (48 h). Samples were assayed for total A␤ production according to Ref. for each construct the density of the glycosylated band has been expressed as a percentage of the total recombinant protein (n Ն 3). The PS1 sequences cloned into pEGFP-␤ were Leu271-Pro433 (cHR 7-9), Leu271-Iso467 (cHR 7-10), Met1-Pro433 (cHR 1-9), and Met1-Iso467 (cHR 1-10; full-length PS1). In cHR 1-10 (RD), the PS1 residues Leu443 and Val444 of cHR1-10 were mutated to Arg and Glu, respectively (Fig. 1B) .
terminal end (Fig. 1B) . In the Western blot shown in Fig. 4A , probed with the antibody PS1-N against the NTF of PS1, we find that the PS1-NGT holoprotein is 91 Ϯ 3% (n ϭ 3) glycosylated, indicating that the COOH terminus of this minimally modified version of PS1 is likewise exposed to the ER lumen.
In Fig. 4B we show the results of experiments where PS1-NGT was transiently or stably expressed in HEK-293 cells. Western blots of membranes from these cells as well as membranes from untreated cells were probed with the antibody PS1-loop that recognizes the CTF of PS1. As in Fig. 4A we find that the PS1-NGT holoprotein is highly glycosylated. In addition, in these cells we observe a band running above the CTF of PS1 that is lost after treatment with PNGase F (marked with an asterisk). The presence of this glycosylated band, which is not seen in nontransfected cells, indicates that the recombinant glycosylated protein PS1-NGT undergoes normal endoproteolytic maturation like wild-type PS1. In additional experiments (not shown), we have not been able to detect a component of endoglycosidase H-resistant complex glycosylation associated with PS1-NGT. Because complex glycosylation takes place in the Golgi, this observation is consistent with the prominent localization of PS1 to the ER. However, this does not preclude the existence of a small component of complex-glycosylated PS1-NGT that is undetectable in our experiments, especially because these bands often tend to be quite diffuse.
To test whether PS1-NGT could produce functional ␥-secretase activity, we transiently expressed it in BD-1 cells [which have no endogenous ␥-secretase activity because they lack both PS1 and PS2 (11)], and measured the production of APP cleavage products (Total A␤) in the extracellular solution. As illustrated in Fig. 4C , this glycosylation mutant yielded similar activity to wild-type PS1. In Western blots of membranes from transfected BD-1 cells, we were unable to detect any significant component of unglycosylated PS1-NGT (Fig. 4D) .
Relationship to previous topology studies of PS1. As already discussed, our data from endogenously expressed PS1 indicating that the NH 2 terminus and loop region between HRs 6 and 8 are cytosolic (Fig. 2 ) are in agreement with the conclusions of most other groups that have studied the PS1 topology. Dewji and Singer (6, 7) have presented evidence that the epitopes of antibodies directed against the NH 2 terminus and loop regions are accessible on the surface of unpermeabilized cells. Similar results were found by Schwarzman et al. (23) using an NH 2 terminal antibody. While we cannot exclude the possibility that there is a pool of PS1 on the cell surface with an opposite orientation, our results are consistent with the conclusion that the vast majority of PS1 molecules that are synthesized in the ER have their NH 2 terminus and loop regions in the cytoplasm.
Our conclusion that the COOH terminus of HR 9 is cytosolic (Fig. 3) is in agreement with all groups that have studied the PS1 topology. In addition, our results provide strong evidence that HR 10 is a MSS and that the COOH terminal tail of PS1 is located in the ER lumen where it is inaccessible to proteinase K applied from the cytosolic compartment and accessible to luminal oligosaccharyl transferase (Figs. 3 and 4) . As discussed previously, these findings are in agreement with the results of Nakai et al. (18, 19) for the PS1 homologue SEL-12 places HR 10 in the cytosol of C. elegans, our results provide strong evidence that this is not the case for PS1 in the mammalian cell lines we have tested.
Two groups that have examined the accessibility of PS1 COOH terminal antibody epitopes also concluded that the COOH terminus of PS1 is cytosolic (6 -8), i.e., that COOH terminal epitopes are not accessible in cells without treatment with membrane permeabilizing agents. However, experiments of this type are complicated by the fact that that the majority of PS1 is localized to intracellular membranes (8) , and that permeabilizing agents may also alter epitope affinity and/or accessibility independent of their permeabilizing effects. To distinguish between cytosolic and luminal epitopes these experiments depend on agents that selectively permeabilize the plasma membrane without permeabilizing intracellular compartments. Because of the large amount of intracellular PS1, even a small permeabilization of intracellular membranes could potentially confound their interpretation. Also, the COOH terminal antibody used by one of these groups (6, 7) was raised against a 9-amino-acid peptide from human PS2 (STDNLVRPF), which is homologous to amino acids 448 -456 of human PS1 (ATDYLVQPF); but the first 6 amino acids of this peptide actually lie within HR 10 of PS1 (Fig. 1B) . Because we place HR 10 in the bilayer we would not have expected this epitope to be accessible from either side of the membrane in the absence of detergent.
Finally, we note that in a recent publication Friedmann et al. (13) have studied the topology of five homologues of the presenilins found in the human genome. These include signal peptide peptidase and four signal peptide peptidase-like (putative) proteases. Interestingly, they propose that all five of these proteins have a nine MSS topology with extracellular NH 2 termini and intracellular COOH termini, i.e., with termini in the reverse orientation to our findings for PS1. Because of their reverse orientation in the membrane these proteins are thought to be intramembranous proteases acting on type II membrane proteins as substrates (13) .
